Company intelligence / Profile preview
Anke Bio
- Ownership
- Private
- Employees
- ~2800
- Development stage
- Other
Overview
Anke Bio is a prominent Chinese biopharmaceutical company focused on the development and commercialization of recombinant DNA products and diagnostic reagents. The company is widely recognized for its market-leading endocrinology portfolio, specifically its recombinant human growth hormone product, Ansomone. In addition to growth hormones, Anke Bio produces interferon-based therapies for infectious diseases and is actively expanding into the oncology sector with biosimilars and innovative cell therapies. Through its subsidiary PersonGen, the company is advancing a pipeline of CAR-T cell therapies targeting various hematological and solid tumors. Headquartered in Hefei, Anke Bio maintains integrated R&D and large-scale GMP manufacturing capabilities to support its domestic and international growth.
- Therapeutic areas
- OncologyEndocrinologyInfectious Diseases
- Modalities
- HormoneCytokineMonoclonal antibodyCAR-T cell therapyRecombinant protein
- Industry
- Biotech
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Anke Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anke Bio.